Early clinical development
Phase 1 expertise includes first-in-human, dose tolerance, PK and PD studies. Study support addresses site readiness, protocol adherence, drug administration and sample collection.
Our servicesBuilt around
Built around
your science.
Connected at
every step.
Full-service clinical development shaped by the specific demands of retina research—from early clinical studies through late-phase programs.
A coordinated approachSpecialization
Specialization
runs through
everything.
Build a program around the support you need, with direct access to experienced leadership and teams who understand retina.
Talk through your programClinical operations
Project management, clinical monitoring, study start-up and site support, coordinated around the demands of your retina program.
- Project management from single-center Phase 1 to large global programs
- Clinical monitoring by professionals dedicated to retina research
- Site budgets, contracts, grants and investigator payment management
- Regulatory documentation, eTMF and study coordination
Medical & scientific leadership
Embedded medical leadership and access to a retina-specialty Scientific Advisory Board bring clinical context to protocol development and trial oversight.
- Protocol development and scientific input
- Full-service medical monitoring
- Data safety monitoring
- Advisory board development and management
Data management & biostatistics
Experienced data management and biostatistics support, with flexibility to work within the technology environment your study requires.
- CRF development and EDC configuration
- Data cleaning, validation and reporting
- Biostatistical support and SAS programming
- Experience with Medidata Rave, Merative and Medrio
Global study delivery
Global project leadership connects study strategy with regional operations, investigators and service partners.
- International project management and regulatory coordination
- Site feasibility and selection informed by RTI
- Collaboration with reading centers and specialty providers
- Partnerships supporting European sites and imaging assessments
Safety & pharmacovigilance
Safety management capabilities support consistent processes, documented assessment and reporting throughout clinical development.
- Safety SOP and manual development and oversight
- Serious adverse event narratives
- Safety review committee reporting
- Coordination with medical monitoring
Digital & study support
Purpose-built communications and study tools help sponsors and sites access the information they need.
- Sponsor-branded, password-protected study portals
- Study newsletters, enrollment communications and focused training tips
- eVision CTMS and eTMF, including monitoring visit calendars
- Participant reimbursement support through InFocus Cash Cards
- Investigator meetings, advisory boards and meeting materials
Across the development journey01 02–03 04+
Experience at every phase.
Proof of concept to pivotal
Clinical operations for complex, multi-site programs, including investigator selection, training, regulatory documentation, safety reporting and coordinated data collection.
Beyond pivotal studies
Phase 4, investigator-initiated and other programs benefit from established site relationships, global coordination and sustained site engagement.
Connected study deliveryKeep information
Keep information
in motion.
Study portals, eVision CTMS and eTMF, targeted newsletters, participant payment support and investigator meetings connect the operational details that matter.
Our meeting planning team can develop agendas, briefing documents, presentations and minutes for scientific advisory boards and investigator meetings.
Explore our technology advantageYour next breakthrough starts with a conversationLet’s move retina
Discuss your study